Allotment

The Trualt Bioenergy Ltd. IPO was launched as a book-built public issue with a total size of ₹839.28 crore. The offering included a fresh issue of around 1.51 crore equity shares amounting to ₹750.00 crore, along with an offer for sale of approximately 0.18 crore shares aggregating to ₹89.28 crore.
The IPO opened for subscription on September 25, 2025, and closed on September 29, 2025. Share allotment was completed on September 30, 2025, and the company’s equity shares were subsequently listed on both the BSE and NSE on October 3, 2025.
The price band for the Trualt Bioenergy IPO was fixed at ₹496 per share. Investors were required to apply in a minimum lot size of 30 shares. Based on the upper price band, the minimum investment for retail investors was ₹14,880. For non-institutional investors, the minimum application size for sNII was 14 lots, or 420 shares, involving an investment of ₹2,08,320, while bNII investors were required to apply for 68 lots, or 2,040 shares, amounting to ₹10,11,840.
Dam Capital Advisors Ltd. acted as the book running lead manager for the issue, while Bigshare Services Pvt. Ltd. served as the registrar to the IPO.
If you want this rewritten in a shorter summary, SEO-friendly IPO format, or simplified language, I can adjust it accordingly.
₹4960%
Open
HIgh - Low
Previous Close
Total Traded Value
52 Weeks High
52 Weeks Low
Updates On
IPO. Open
IPO. Close
IPO. Price
IPO Market price
| IPO Date | 3 Oct |
| IPO Listing Date | 3 Oct |
| IPO Face Value | ₹10 per share |
| IPO Price Range | ₹496.00 |
| IPO Issue Size | 1,69,20,967 shares |
| IPO Sale Type | Fresh Capital & OFS |
| Employee Discount | - |
| IPO Issue Type | Bookbuilding IPO |
| IPO Listing | BSE, NSE Platform |
| Share Holding Pre Issue | 7,06,31,624 shares |
| IPO Open Date | 25 Sep |
| IPO Close Date | 29 Sep |
| IPO Allotment (Tentative) | 30 Sep |
| Refunds | 1 Oct |
| Credit to Demat Account | 1 Oct |
| IPO Listing Date | 3 Oct |
| Category | Offer |
|---|---|
| QIB Shares Offered | 84,60,482 (50.00%) |
| NII (HNI) Shares Offered | 25,38,146 (15.00%) |
| Retail Shares Offered | 59,22,339 (35.00%) |
Investors can bid for a minimum of 30 shares, with additional shares available in multiples of 30.
| Application | Lots | Share | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 30 | ₹14,880 |
| Retail (Max) | 13 | 390 | ₹1,93,440 |
| S-HNI (Min) | 14 | 420 | ₹2,08,320 |
| S-HNI (Max) | 67 | 2,010 | ₹9,96,960 |
| B-HNI (Min) | 68 | 2,040 | ₹10,11,840 |
Trualt Bioenergy Limited was established in 2021 and operates in the renewable energy space, with a strong emphasis on biofuel manufacturing, particularly ethanol. Based on an installed production capacity of 2,000 kilolitres per day, the company ranks among India’s leading ethanol producers. During Fiscal 2025, it accounted for approximately 3.6% of the country’s total ethanol production capacity.
The company’s operations cover both ethanol manufacturing and compressed biogas (CBG) production. As of March 31, 2025, its subsidiary, Leafinity, managed a CBG facility with a processing capacity of 10.20 tonnes per day. To accelerate growth in this segment, Trualt Bioenergy has signed memorandums of understanding with a Japanese gas company and Sumitomo Corporation Asia & Oceania Pte. Ltd., aimed at expanding its CBG production footprint.
According to the red herring prospectus, the company operates five distillery units located in Karnataka, of which four use molasses and syrup-based raw materials for ethanol production.
In addition to its existing activities, Trualt Bioenergy plans to diversify into new segments such as second-generation ethanol, sustainable aviation fuel, and the production of Mevalonolactone (MVL) along with other allied biochemical products.
The company’s strengths include its large-scale ethanol production capacity, integrated resource management that supports scalable operations, and strategically positioned manufacturing facilities with a focus on technology-driven and sustainable practices. It is well placed to benefit from favorable industry trends, supported by long-standing customer relationships, a strong order pipeline, and an experienced promoter group and management team.
| Assets | 3,029.73 | 2,419.08 | - |
| Total Income | 1,968.53 | 1,280.19 | - |
| Profit After Tax | 146.64 | 31.81 | - |
| EBITDA | 309.14 | 188.09 | - |
| NET Worth | 769 | 264.61 | - |
| Reserves and Surplus | 1,549.68 | 1,684.68 | - |
| Total Borrowing | - | - | - |
| ROE | 28.27% |
| ROCE | 10.88% |
| Debt/Equity | 2.02 |
| RoNW | 19.07% |
| PAT Margin | 7.69% |
| EBITDA Margin | 16.20% |
| Price to Book Value | 4.56 |
IPO Objects of the Issue
| S.No. | Objects of the ipo Resources Detail | IPO Amount |
|---|---|---|
| 1 | Funding capital expenditure requirements for the purchase of equipment/machineries | - |
| 2 | To meet out the expenses of Working Capital Requirement | 425.00 |
| 3 | To meet out the General Corporate Purposes; | 81.36 |
| 4 | Offer for Sale (OFS) | - |
Trualt Bioenergy Limited
Survey No. 166, Kulali Cross
Jamkhandi–Mudhol Road, Bagalkot
Karnataka – 587313, India
Phone: 080 2325 5000
Email: cs@trualtbioenergy.com
Website: www.trualtbioenergy.com
IPO Registrar
Bigshare Services Pvt.Ltd.
+91-22-6263 8200
ipo@bigshareonline.com
https://ipo.bigshareonline.com/IPO_Status.html